Advertisement

Multidrug Resistance Proteins and Hepatic Transport of Endo- and Xenobiotics

  • Phillip M. Gerk
  • Mary Vore
Protocol
Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Abstract

Transporters that use ATP are called ATP-binding cassette (ABC) transporters. One family of ABC transporters that plays a major role in the ability of the liver to eliminate various drugs is the multidrug resistance proteins (MRPs). There are nine cloned genes in the MRP (ABCC) subfamily. Generally, these carriers transport diverse sulfate, glutathione, or glucuronide conjugates of endogenous compounds like estrogen and bilirubin, as well as drugs and toxins. Although all of the MRPs mediate ATP-dependent efflux, their tissue expression and cellular localization vary. MRP2 is most highly expressed in the liver at the canalicular domain and is the primary focus of this chapter. Several in vitro approaches to study drug transport in the liver are discussed. Although these approaches have been described in detail elsewhere, the authors present their own perspectives, with particular emphasis on the baculovirus expression vector system. Additional methods and approaches that are discussed include the choice of animal tissue preparation, expression system to be used, and experimental paradigms, including uptake in membrane vesicles, cell monolayers, and procedures to measure ATPase activity and its relationship to transport.

Key Words

ATPase activity ATP-binding cassette transporters baculovirus expression expression systems hepatocytes liver membrane vesicles multidrug resistance associated proteins Sf9 cell culture Sf9 membrane vesicle preparation 

References

  1. 1.
    Stein WD. Channels, Carriers, and Pumps: An Introduction to Membrane Transport. San Diego: Academic Press; 1990.Google Scholar
  2. 2.
    Holland IB, Blight MA. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J Mol Biol 1999;293:381–399.PubMedCrossRefGoogle Scholar
  3. 3.
    Stein WD. Transport and Diffusion Across Cell Membranes. San Diego: Academic Press; 1986.Google Scholar
  4. 4.
    Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001;11:1156–1166.Google Scholar
  5. 5.
    Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537–592.PubMedCrossRefGoogle Scholar
  6. 6.
    Faber KN, Muller M, Jansen PL. Drug transport proteins in the liver. Adv Drug Deliv Rev 2003;55:107–124.PubMedCrossRefGoogle Scholar
  7. 7.
    Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003;83:633–671.PubMedGoogle Scholar
  8. 8.
    Ballatori N, Rebbeor JF. Roles of MRP2 and oatp1 in hepatocellular export of reduced glutathione. Semin Liver Dis 1998;18:377–387.PubMedCrossRefGoogle Scholar
  9. 9.
    Gerk PM, Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 2002;302:407–415.PubMedCrossRefGoogle Scholar
  10. 10.
    Keppler D, Leier I, Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997;378:787–791.PubMedGoogle Scholar
  11. 11.
    Shoda J, Kano M, Oda K, et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 2001;96:3368–3378.PubMedCrossRefGoogle Scholar
  12. 12.
    Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin Liver Dis 2000;20:273–292.PubMedCrossRefGoogle Scholar
  13. 13.
    Huang L, Smit JW, Meijer DK, Vore M. Mrp2 is essential for estradiol-17β(β-d-glucuronide)-induced cholestasis in rats. Hepatology 2000;32:66–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Boyer JL, Meier PJ. Characterizing mechanisms of hepatic bile acid transport utilizing isolated membrane vesicles. Methods Enzymol 1990;192:517–533.PubMedCrossRefGoogle Scholar
  15. 15.
    Meier PJ, Boyer JL. Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processes. Methods Enzymol 1990;192:534–545.PubMedCrossRefGoogle Scholar
  16. 16.
    Suzuki H, Sugiyama Y. Transporters for bile acids and organic anions. Pharm Biotechnol 1999;12:387–439.PubMedCrossRefGoogle Scholar
  17. 17.
    Evers R, de Haas M, Sparidans R, et al. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 2000;83:375–383.PubMedCrossRefGoogle Scholar
  18. 18.
    Loe DW, Almquist KC, Cole SP, Deeley RG. ATP-dependent 17 β-estradiol 17-(β-d-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 1996;271:9683–9689.PubMedCrossRefGoogle Scholar
  19. 19.
    Ryu S, Kawabe T, Nada S, Yamaguchi A. Identification of basic residues involved in drug export function of human multidrug resistance-associated protein 2. J Biol Chem 2000;275:39617–39624.PubMedCrossRefGoogle Scholar
  20. 20.
    Shapiro AB, Ling V. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem 1994;269:3745–3754.PubMedGoogle Scholar
  21. 21.
    Hagmann W, Nies AT, Konig J, Frey M, Zentgraf H, Keppler D. Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase. Eur J Biochem 1999;265:281–289.PubMedCrossRefGoogle Scholar
  22. 22.
    Borst P, Evers R, Kool M, Wijnholds J. The multidrug resistance protein family. Biochim Biophys Acta 1999;1461:347–357.PubMedCrossRefGoogle Scholar
  23. 23.
    O’Reilly DR, Miller LK, Luckow VA. Baculovirus expression vectors: a laboratory manual. New York: Oxford University Press; 1994.Google Scholar
  24. 24.
    van Aubel RA, van Kuijck MA, Koenderink JB, Deen PM, van Os CH, Russel FG. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol Pharmacol 1998;53:1062–1067.PubMedGoogle Scholar
  25. 25.
    Bohme M, Muller M, Leier I, Jedlitschky G, Keppler D. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 1994;107:255–265.PubMedGoogle Scholar
  26. 26.
    Konno T, Ebihara T, Hisaeda K, et al. Identification of domains participating in the substrate specificity and subcellular localization of the multidrug resistance proteins MRP1 and MRP2. J Biol Chem 2003;278:22908–22917.PubMedCrossRefGoogle Scholar
  27. 27.
    Ito K, Suzuki H, Sugiyama Y. Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate. Am J Physiol 2001;281:G1034–G1043.Google Scholar
  28. 28.
    Tabas LB, Dantzig AH. A high-throughput assay for measurement of multidrug resistance protein-mediated transport of leukotriene C4 into membrane vesicles. Anal Biochem 2002;310:61–66.PubMedCrossRefGoogle Scholar
  29. 29.
    Akita H, Suzuki H, Ito K, et al. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 2001;1511:7–16.PubMedCrossRefGoogle Scholar
  30. 30.
    Cui Y, Konig J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 2001;60:934–943.PubMedGoogle Scholar
  31. 31.
    Hidalgo IJ, Hillgren KM, Grass GM, Borchardt RT. A new side-by-side diffusion cell for studying transport across epithelial cell monolayers. In Vitro Cell Dev Biol 1992;28A:578–580.PubMedCrossRefGoogle Scholar
  32. 32.
    Hidalgo IJ, Hillgren KM, Grass GM, Borchardt RT. Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus. Pharm Res 1991;8:222–227.PubMedCrossRefGoogle Scholar
  33. 33.
    Yu H, Sinko PJ. Influence of the microporous substratum and hydrodynamics on resistances to drug transport in cell culture systems: calculation of intrinsic transport parameters. J Pharm Sci 1997;86:1448–1457.PubMedCrossRefGoogle Scholar
  34. 34.
    Polli JW, Wring SA, Humphreys JE, et al. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 2001;299:620–628.PubMedGoogle Scholar
  35. 35.
    Litman T, Druley TE, Stein WD, Bates SE. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001;58:931–959.PubMedCrossRefGoogle Scholar
  36. 36.
    Saheki S, Takeda A, Shimazu T. Assay of inorganic phosphate in the mild pH range, suitable for measurement of glycogen phosphorylase activity. Anal Biochem 1985;148:277–281.PubMedCrossRefGoogle Scholar
  37. 37.
    Bakos E, Evers R, Sinko E, Varadi A, Borst P, Sarkadi B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol 2000;57:760–768.PubMedGoogle Scholar
  38. 38.
    Drueckes P, Schinzel R, Palm D. Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Anal Biochem 1995;230:173–177.PubMedCrossRefGoogle Scholar
  39. 39.
    Van Aubel RA, Peters JG, Masereeuw R, Van Os CH, Russel FG. Multidrug resistance protein mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate. Am J Physiol 2000;279:F713–F717.Google Scholar
  40. 40.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275.Google Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Phillip M. Gerk
    • 1
  • Mary Vore
    • 1
  1. 1.Graduate Center for ToxicologyUniversity of Kentucky Medical CenterLexington

Personalised recommendations